Showing 301 - 320 results of 65,367 for search '(( 50 ng decrease ) OR ( 5 ((((mm decrease) OR (a decrease))) OR (we decrease)) ))', query time: 0.78s Refine Results
  1. 301

    Test joint. by Jianbo Jia (717814)

    Published 2024
    Subjects:
  2. 302
  3. 303
  4. 304
  5. 305
  6. 306

    The well wall step. by Jianbo Jia (717814)

    Published 2024
    Subjects:
  7. 307

    Fig 17 - by Jianbo Jia (717814)

    Published 2024
    Subjects:
  8. 308

    Fig 11 - by Jianbo Jia (717814)

    Published 2024
    Subjects:
  9. 309

    Fig 9 - by Jianbo Jia (717814)

    Published 2024
    Subjects:
  10. 310

    Fig 7 - by Jianbo Jia (717814)

    Published 2024
    Subjects:
  11. 311
  12. 312
  13. 313
  14. 314
  15. 315
  16. 316
  17. 317
  18. 318

    Image4_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
  19. 319

    Image2_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
  20. 320

    Image6_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”